Search | TVST | ARVO Journals

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Duration of viral load, clinical signs, and symptoms in qPCR-confirmed adenoviral conjunctivitis

Christina E Morettin; Jennifer S Harthan; Tammy Than; Ellen Shorter; Andrew TE Hartwick; Julie B Huecker; Spencer D Johnson; Mary K Migneco; Meredith Whiteside; Christian K Olson; Christopher S Alferez; Tave van Zyl; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2938.

Articles August 2021

Predictive Accuracy and Densitometric Analysis of Point-of-Care Immunoassay for Adenoviral Conjunctivitis

PDF

Spencer D. Johnson; Jennifer S. Harthan; Tammy Than; Mary K. Migneco; Ellen Shorter; Meredith M. Whiteside; Christina E. Morettin; Christian K. Olson; Crystal A. Rosemann; Mathew S. Margolis; Leonard W. Haertter; Julia B. Huecker; Bojana Rodic-Polic; Richard S. Buller; Gregory A. Storch; Mae O. Gordon; Andrew T. E. Hartwick
TAGS: adenoviral conjunctivitis, adenoviruses, densitometry, immunoassay, eye, laboratory test finding
Trans. Vis. Sci. Tech.. 2021; 10(9):30. https://doi.org/10.1167/tvst.10.9.30

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Reducing Adenoviral Patient Infected Days (RAPID) Study: Correlation of adenoviral load with severity of adenoviral conjunctivitis and viral clearance over 21 days

Christina E Morettin; Jennifer S Harthan; Julia Huecker; AA Chamila D Perera; Tammy P Than; Ellen Shorter; Meredith Whiteside; Spencer Johnson; Andrew Hartwick; Mathew Margolis; Mary K Migneco; Christopher Alferez; Devon Camp; Len Haertter; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):696.

ARVO Annual Meeting Abstract June 2020

Improving accuracy of adenoviral conjunctivitis diagnosis

Ellen Shorter; Chamila Perera; Mary Migneco; Meredith Whiteside; Jennifer Harthan; Andrew Hartwick; Spencer Johnson; Christina Morettin; Julia Huecker; Tammy Than; Mae Gordon

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4900.

ARVO Annual Meeting Abstract July 2019

The Reducing Adenoviral Patient-Infected Days (RAPID) Study: Safety and Tolerability of One-Time, In-Office Application of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis

Ellen Shorter; Tammy Than; Meredith Whiteside; Jennifer S Harthan; Mathew Margolis; Spencer Johnson; Mary Migneco; Christina Morettin; Christian K. Olson; Andrew Hartwick; Julia Huecker; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4703.

ARVO Annual Meeting Abstract July 2019

Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis

Andrew Hartwick; Tammy Than; Bojana Rodic-Polic; Spencer Johnson; Mary Migneco; Ellen Shorter; Jennifer S Harthan; Christina Morettin; Meredith Whiteside; Christian K. Olson; Mathew Margolis; Julia Huecker; Gregory Storch; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6257.

ARVO Annual Meeting Abstract July 2018

Reducing Adenoviral Patient Infected Days (RAPID): Prevalence of Polymerase Chain Reaction (PCR) Confirmed Adenovirus Among Patients Presenting With Acute Conjunctivitis

Mary Migneco; Mathew Margolis; Christina Morettin; Tammy Than; Meredith Whiteside; Ellen Shorter; Jennifer S Harthan; Spencer Johnson; Andy Hartwick; Kelly Olsen; Tave van Zyl; Julia Huecker; Crystal Rosemann; Mae O. Gordon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):115.

ARVO Annual Meeting Abstract July 2018

Reducing Adenoviral Patient Infected Days (RAPID) Study: Success in Masking Subjects and Clinicians From Identifying Treatment with Ophthalmic Povidone-Iodine 5% (PVP-I).

Meredith Whiteside; Ellen Shorter; Mary Migneco; Andy Hartwick; Tammy Than; Jennifer S Harthan; Christina Morettin; Spencer Johnson; Mathew Margolis; Julia Huecker; Kelly Olsen; Crystal Rosemann; Tave' van Zyl; Timothy Bossie; Mae Gordon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3788.

ARVO Annual Meeting Abstract June 2017

Reducing Adenoviral Patient Infected Days (RAPID) Study: Association of Clinical Signs and Symptoms with qPCR confirmed Adenoviral Conjunctivitis

Ellen Shorter; Mary Migneco; Jennifer S Harthan; Meredith Whiteside; Christina Morettin; Tammy Than; Spencer Johnson; Julia Huecker; Andrew T E Hartwick; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4360.

ARVO Annual Meeting Abstract September 2016

Reducing Adenoviral Patient Infected Days (RAPID) Planning Study: Agreement between Clinician and AdenoPlus TM in the Diagnosis of Adenoviral Conjunctivitis

Mary Migneco; Mae O Gordon; Andrew T E Hartwick; Spencer Johnson; Jennifer Harthan; Christina Morettin; Tammy Than; Ellen Shorter; Julie Huecker

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3503.

ARVO Annual Meeting Abstract June 2013

Correlations between non-stimulated tear levels and conjunctival surface expression of inflammation-related biomarkers in normal and aqueous-deficient dry eye patients

Roderick Fullard; John Bradley; Larezia Williams; My-Tho Tran; Nicole Guyette; Tammy Than; Pearl Shin

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4360.

Cornea May 2013

Comparison of Low-Abundance Biomarker Levels in Capillary-Collected Nonstimulated Tears and Washout Tears of Aqueous-Deficient and Normal Patients

PDF

Nicole Guyette; Larezia Williams; My-Tho Tran; Tammy Than; John Bradley; Lucy Kehinde; Clara Edwards; Mark Beasley; Roderick Fullard
TAGS: biological markers, blood capillaries, cytokine, dry eye syndromes
Invest. Ophthalmol. Vis. Sci.. 2013; 54(5):3729-3737. https://doi.org/10.1167/iovs.12-11431

ARVO Annual Meeting Abstract March 2012

Conjunctival Gene Expression Patterns in Dry Eye; Real Time PCR and Beyond

John L. Bradley; Keshia S. Elder; Tammy P. Than; Roderick J. Fullard

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):538.

ARVO Annual Meeting Abstract March 2012

Non-stimulated Tear Levels and Conjunctival Expression of IL-8 and IP-10 in Normal and Dry Eye Patients

Roderick J. Fullard; My-Tho K. Tran; Larezia D. Williams; John L. Bradley; Nicole M. Guyette; Tammy P. Than; Roy Joseph; Landon S. Wilson; Stephen Barnes

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):539.

ARVO Annual Meeting Abstract March 2012

Impedance Osmometry: Standard Solutions

William J. Benjamin; Tammy P. Than

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):562.

ARVO Annual Meeting Abstract March 2012

Effects of Nicotine on Flicker ERGs: Application of DFT and T-Circ2

Stefanie B. Varghese; Naser Naser; Tammy P. Than; Kent T. Keyser; E. Eugenie Hartmann

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5702.

ARVO Annual Meeting Abstract April 2011

Color Vision: Effects of Nicotine Gum in Non-Smokers

Naser T. Naser; Michael Loop; Tammy Than; Stefanie Varghese; E. E. Hartmann

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4902.

ARVO Annual Meeting Abstract April 2011

Correlations between Tear IP-10 and other Biomarkers in Normal and Dry Eye Patients

Tammy P. Than; Nicole Guyette; Karin Tran; Keshia Elder; Janene Sims; Lucy Kehinde; Pearl Shin; Larezia Williams; John Bradley; Roderick Fullard

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3807.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Duration of viral load, clinical signs, and symptoms in qPCR-confirmed adenoviral conjunctivitis

Predictive Accuracy and Densitometric Analysis of Point-of-Care Immunoassay for Adenoviral Conjunctivitis

Reducing Adenoviral Patient Infected Days (RAPID) Study: Correlation of adenoviral load with severity of adenoviral conjunctivitis and viral clearance over 21 days

Improving accuracy of adenoviral conjunctivitis diagnosis

The Reducing Adenoviral Patient-Infected Days (RAPID) Study: Safety and Tolerability of One-Time, In-Office Application of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis

Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis

Reducing Adenoviral Patient Infected Days (RAPID): Prevalence of Polymerase Chain Reaction (PCR) Confirmed Adenovirus Among Patients Presenting With Acute Conjunctivitis

Reducing Adenoviral Patient Infected Days (RAPID) Study: Success in Masking Subjects and Clinicians From Identifying Treatment with Ophthalmic Povidone-Iodine 5% (PVP-I).

Reducing Adenoviral Patient Infected Days (RAPID) Study: Association of Clinical Signs and Symptoms with qPCR confirmed Adenoviral Conjunctivitis

Reducing Adenoviral Patient Infected Days (RAPID) Planning Study: Agreement between Clinician and AdenoPlus TM in the Diagnosis of Adenoviral Conjunctivitis

Correlations between non-stimulated tear levels and conjunctival surface expression of inflammation-related biomarkers in normal and aqueous-deficient dry eye patients

Comparison of Low-Abundance Biomarker Levels in Capillary-Collected Nonstimulated Tears and Washout Tears of Aqueous-Deficient and Normal Patients

Conjunctival Gene Expression Patterns in Dry Eye; Real Time PCR and Beyond

Non-stimulated Tear Levels and Conjunctival Expression of IL-8 and IP-10 in Normal and Dry Eye Patients

Impedance Osmometry: Standard Solutions

Effects of Nicotine on Flicker ERGs: Application of DFT and T-Circ2

Color Vision: Effects of Nicotine Gum in Non-Smokers

Correlations between Tear IP-10 and other Biomarkers in Normal and Dry Eye Patients

To View More...

You must be signed into an individual account to use this feature.